Jacksonville, Florida




Do you want to revolutionize health care? Do you want to conduct groundbreaking research in nanomedicine and tissue regeneration using stem cells? Do you want to be located five minutes from the beach in Florida? If you answered yes to any of these questions, Dr. Wolfram's Nanomedicine and Extracellular Vesicles Laboratory is for you! Join a group of young scientists who are passionate about thinking differently to solve major health care challenges.

Joy Wolfram, Ph.D., focuses her research in nanomedicine on the development of new strategies for the treatment of disease. In particular, her team is developing extracellular vesicle therapeutics and methods for organotropic drug delivery. Dr. Wolfram aspires to generate fruitful interinstitutional research collaborations around the world.

Focus areas

  • Extracellular vesicle therapeutics
  • Cardiovascular disease
  • Organotropic drug delivery
  • Extracellular vesicle diagnostics

Significance to patient care

Dr. Wolfram's research goal is to bring new nanomedicine treatments to Mayo Clinic. Nanotechnology enables the design of multifunctional and targeted therapies, thereby increasing therapeutic efficacy and reducing side effects for patients.

Professional highlights

  • Board member, Pharmatest, 2019-present
  • Co-leader, Regenerative Sciences Training Program, Mayo Clinic Graduate School of Biomedical Sciences, 2019-present
  • Commissioner, Svenska Tekniska Vetenskapsakademien (Swedish Technical Science Academy), Finland, 2019-present
  • Director, Basic Internship in Neuroscience and Cancer, Mayo Clinic, Jacksonville, Florida, 2019-present
  • Member, Global Young Academy, 2019-present
  • Working group member, Biomedical Sciences Program, University of North Florida, 2019-present
  • Board member, Group Dash Ltd., 2018-present
  • Chair, Physical Sciences-Oncology Network Education and Outreach Working Group, National Cancer Institute, 2018-present
  • Editorial board member, Scientific Reports, 2018-present
  • Scientific advisory board member, Genomill Health, 2018-present
  • Associate research professor, Wenzhou Institute of Biomaterials & Engineering, Ningbo Institute of Industrial Technology, China, 2017-present
  • Affiliate assistant faculty member, Department of Nanomedicine, Houston Methodist Research Institute, 2017-present
  • Board member, Bidwater, 2017-present
  • Courtesy research faculty member, Department of Biology, University of North Florida, 2017-present
  • Working group representative, Education and Outreach Unit, Center for Immunotherapeutic Transport Oncophysics of the National Cancer Institute, Houston Methodist Research Institute, 2016-present
  • Board member and co-owner, Oy Wolfram Ab, 2013-present
  • Chair, RNA Nanotechnology Gordon Research Seminar, 2019
  • Named, Forbes 30 Under 30, U.S. & Canada, 2019
  • Shortlisted, Nature Research Award for Inspiring Science, 2019
  • Speaker, "The Promise of Nanomedicine," TEDx, 2018
  • Internationally Accomplished Finn, Inspired in Finland, 2017
  • Named, Amgen Scholars Ten to Watch List, Amgen Foundation, 2016


See my publications


Administrative Appointment

  1. Associate Consultant I-Research, Department of Physiology and Biomedical Engineering
  2. Associate Consultant I-Research, Department of Biochemistry and Molecular Biology
  3. Associate Consultant I-Research, Department of Transplantation

Academic Rank

  1. Assistant Professor of Medicine


  1. PhD - In collaboration with the Houston Methodist Hospital, Houston, Texas, United States University of Chinese Academy of Sciences
  2. MS University of Helsinki
  3. BS University of Helsinki

Mayo Clinic Footer